全球心臟再同步治療系統市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

全球心臟再同步治療系統市場需求預計將從 2023 年的 55.3 億美元達到近 86.8 億美元的市場規模，2024 年至 2032 年的研究期間CAGR為 5.14%。

心臟再同步治療 (CRT) 系統是用於治療心臟衰竭的醫療設備。它們涉及植入起搏器等裝置來同步心室的收縮，從而改善整體心臟功能。

市場動態

心臟再同步治療系統市場是由塑造心血管醫療保健格局的多種因素所驅動的。心臟衰竭盛行率的增加，加上人口老化的加劇，擴大了對先進心臟治療的需求。涉及心室同步起搏的心臟再同步治療（CRT）系統已成為增強心臟功能的關鍵干預措施。人們對心臟衰竭管理的認知不斷增強，加上植入式設備的技術進步，推動了市場的擴張。支持性的報銷政策和醫療保健基礎設施的發展進一步促進了 CRT 系統的可近性。此外，醫療專業人員、設備製造商和研究機構之間的合作推動了心臟治療的持續創新，促進了 CRT 系統市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球心臟再同步治療系統市場的各個細分市場進行了包容性評估。心臟再同步治療系統產業的成長和趨勢為本研究提供了整體方法。

市場區隔

心臟再同步治療系統市場報告的這一部分提供了國家和區域層級細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依產品類型

• 心臟再同步治療起搏器
• 心臟再同步治療去顫器

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心臟再同步治療系統市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心臟再同步治療系統市場的主要參與者包括美敦力、波士頓科學公司、雅培、LivaNova PLC、BIOTRONIK SE & Co. KG、旭化成醫療有限公司、NIHON KOHDEN CORPORATION、Schiller AG。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：心臟再同步治療系統 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 市場吸引力分析：按產品類型
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球心臟再同步治療系統市場分析：依產品類型

• 概述：按產品類型
• 歷史和預測數據
• 分析：依產品類型
• 心臟再同步治療起搏器
• 心臟再同步治療去顫器

第 6 章：全球心臟再同步治療系統市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 7 章：心臟再同步治療系統公司的競爭格局

• 心臟再同步治療系統市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 8 章：公司簡介

• 公司股份分析
• 市場集中度
• Medtronic
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Boston Scientific Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Abbott
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• LivaNova PLC
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• BIOTRONIK SE & Co. KG
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Asahi Kasei Medical Co. Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• NIHON KOHDEN CORPORATION
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Schiller AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Cardiac Resynchronization Therapy Systems Market is presumed to reach the market size of nearly USD 8.68 Billion by 2032 from USD 5.53 Billion in 2023 with a CAGR of 5.14% under the study period 2024 - 2032.

Cardiac Resynchronization Therapy (CRT) Systems are medical devices used to treat heart failure. They involve the implantation of devices like pacemakers to synchronize the contractions of the heart chambers, improving overall cardiac function.

MARKET DYNAMICS

The cardiac resynchronization therapy systems market is driven by multiple factors shaping the landscape of cardiovascular healthcare. The increasing prevalence of heart failure, coupled with a rising aging population, has amplified the demand for advanced cardiac therapies. Cardiac Resynchronization Therapy (CRT) Systems involving synchronized pacing of the heart chambers have emerged as a crucial intervention for enhancing cardiac function. The growing awareness of heart failure management, coupled with technological advancements in implantable devices, propels market expansion. Supportive reimbursement policies and healthcare infrastructure development further contribute to the accessibility of CRT systems. Moreover, collaborative efforts between medical professionals, device manufacturers, and research institutions drive continuous innovation in cardiac therapies, fostering the growth of the CRT systems market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiac resynchronization therapy systems. The growth and trends of cardiac resynchronization therapy systems industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cardiac resynchronization therapy systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Cardiac Resynchronization Therapy Pacemaker
• Cardiac Resynchronization Therapy Defibrillator

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Resynchronization Therapy Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Resynchronization Therapy Systems market include Medtronic, Boston Scientific Corporation, Abbott, LivaNova PLC, BIOTRONIK SE & Co. KG, Asahi Kasei Medical Co., Ltd., NIHON KOHDEN CORPORATION, Schiller AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET ANALYSIS BY PRODUCT TYPE

• 5.1 Overview by Product Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product Type
• 5.4 Cardiac Resynchronization Therapy Pacemaker Historic and Forecast Sales by Regions
• 5.5 Cardiac Resynchronization Therapy Defibrillator Historic and Forecast Sales by Regions

6 . GLOBAL CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET ANALYSIS BY GEOGRAPHY

• 6.1. Regional Outlook
• 6.2. Introduction
• 6.3. North America Sales Analysis
  • 6.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.3.2. North America By Segment Sales Analysis
  • 6.3.3. North America By Country Sales Analysis
  • 6.3.4. United State Sales Analysis
  • 6.3.5. Canada Sales Analysis
  • 6.3.6. Mexico Sales Analysis
• 6.4. Europe Sales Analysis
  • 6.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.4.2. Europe by Segment Sales Analysis
  • 6.4.3. Europe by Country Sales Analysis
  • 6.4.4. United Kingdom Sales Analysis
  • 6.4.5. France Sales Analysis
  • 6.4.6. Germany Sales Analysis
  • 6.4.7. Italy Sales Analysis
  • 6.4.8. Russia Sales Analysis
  • 6.4.9. Rest Of Europe Sales Analysis
• 6.5. Asia Pacific Sales Analysis
  • 6.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.5.2. Asia Pacific by Segment Sales Analysis
  • 6.5.3. Asia Pacific by Country Sales Analysis
  • 6.5.4. China Sales Analysis
  • 6.5.5. India Sales Analysis
  • 6.5.6. Japan Sales Analysis
  • 6.5.7. South Korea Sales Analysis
  • 6.5.8. Australia Sales Analysis
  • 6.5.9. South East Asia Sales Analysis
  • 6.5.10. Rest Of Asia Pacific Sales Analysis
• 6.6. Latin America Sales Analysis
  • 6.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.6.2. Latin America by Segment Sales Analysis
  • 6.6.3. Latin America by Country Sales Analysis
  • 6.6.4. Brazil Sales Analysis
  • 6.6.5. Argentina Sales Analysis
  • 6.6.6. Peru Sales Analysis
  • 6.6.7. Chile Sales Analysis
  • 6.6.8. Rest of Latin America Sales Analysis
• 6.7. Middle East & Africa Sales Analysis
  • 6.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.7.2. Middle East & Africa by Segment Sales Analysis
  • 6.7.3. Middle East & Africa by Country Sales Analysis
  • 6.7.4. Saudi Arabia Sales Analysis
  • 6.7.5. UAE Sales Analysis
  • 6.7.6. Israel Sales Analysis
  • 6.7.7. South Africa Sales Analysis
  • 6.7.8. Rest Of Middle East And Africa Sales Analysis

7 . COMPETITIVE LANDSCAPE OF THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS COMPANIES

• 7.1. Cardiac Resynchronization Therapy Systems Market Competition
• 7.2. Partnership/Collaboration/Agreement
• 7.3. Merger And Acquisitions
• 7.4. New Product Launch
• 7.5. Other Developments

8 . COMPANY PROFILES OF CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS INDUSTRY

• 8.1. Company Share Analysis
• 8.2. Market Concentration Rate
• 8.3. Medtronic
  • 8.3.1. Company Overview
  • 8.3.2. Company Revenue
  • 8.3.3. Products
  • 8.3.4. Recent Developments
• 8.4. Boston Scientific Corporation
  • 8.4.1. Company Overview
  • 8.4.2. Company Revenue
  • 8.4.3. Products
  • 8.4.4. Recent Developments
• 8.5. Abbott
  • 8.5.1. Company Overview
  • 8.5.2. Company Revenue
  • 8.5.3. Products
  • 8.5.4. Recent Developments
• 8.6. LivaNova PLC
  • 8.6.1. Company Overview
  • 8.6.2. Company Revenue
  • 8.6.3. Products
  • 8.6.4. Recent Developments
• 8.7. BIOTRONIK SE & Co. KG
  • 8.7.1. Company Overview
  • 8.7.2. Company Revenue
  • 8.7.3. Products
  • 8.7.4. Recent Developments
• 8.8. Asahi Kasei Medical Co. Ltd.
  • 8.8.1. Company Overview
  • 8.8.2. Company Revenue
  • 8.8.3. Products
  • 8.8.4. Recent Developments
• 8.9. NIHON KOHDEN CORPORATION
  • 8.9.1. Company Overview
  • 8.9.2. Company Revenue
  • 8.9.3. Products
  • 8.9.4. Recent Developments
• 8.10. Schiller AG
  • 8.10.1. Company Overview
  • 8.10.2. Company Revenue
  • 8.10.3. Products
  • 8.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product Type (USD MN)
• Cardiac Resynchronization Therapy Pacemaker Market Sales by Geography (USD MN)
• Cardiac Resynchronization Therapy Defibrillator Market Sales by Geography (USD MN)
• Global Cardiac Resynchronization Therapy Systems Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cardiac Resynchronization Therapy Systems Report
• Market Research Process
• Market Research Methodology
• Global Cardiac Resynchronization Therapy Systems Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product Type
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis By Product Type (USD MN)
• Cardiac Resynchronization Therapy Pacemaker Market Sales by Geography (USD MN)
• Cardiac Resynchronization Therapy Defibrillator Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.